Mark Your Calendar for Lymphoma, Leukemia & Myeloma Congress 2026

Join hematology-oncology professionals from around the world for the 2026 Lymphoma, Leukemia & Myeloma Congress, taking place October 13–16, 2026, in New York City. For more than 25 years, LL&M Congress has provided focused, in-person education on lymphoma, leukemia, and myeloma, bringing clinicians together to advance patient care.

Why Attend LL&M Congress?

  • Broad, disease-focused education across lymphoma, leukemia, myeloma, and CLL

  • Clear application to practice with emphasis on patient management and treatment decisions

  • Faculty who treat patients, combining clinical trial expertise with real-world care

  • Discussion-driven learning through panels, cases, and peer exchange

A Meeting Built for Connection

LL&M Congress brings together a consistent community of hematology-oncology professionals who return year after year to learn, share perspectives, and advance care. The in-person setting creates space for conversation inside sessions and beyond, supporting collaboration and shared learning across disease areas.

Progress Happens When We Come Together

Join Our Mailing List to Stay Informed!

Our Endorsers

Why Clinicians Choose LL&M Congress

The Lymphoma, Leukemia & Myeloma Congress brings hematology-oncology professionals together for focused, in-person learning grounded in evidence, discussion, and real-world care. For more than 25 years, this meeting has served as a place to examine emerging data, share perspectives, and advance care for patients with lymphoma, leukemia, CLL, and myeloma.

  • 4
    Days dedicated to discussion, learning, and shared perspectives
  • 25+
    Years of coming together around hematologic malignancies
  • 1
    Consistent community of clinicians returning year after year to learn and connect

Frequently Asked Questions

What You Need to Know About Lymphoma, Leukemia & Myeloma Congress

What-You-Need-to-Know-About-Lymphoma,-Leukemia-&-Myeloma-Congress

    • What is the Lymphoma, Leukemia & Myeloma Congress?

      The Lymphoma, Leukemia & Myeloma Congress is a leading hematology conference dedicated exclusively to blood cancers. The meeting delivers evidence-based, clinically focused education in lymphoma, leukemia, and multiple myeloma to support real-world oncology decision-making.

    • What makes the Lymphoma, Leukemia & Myeloma Congress different?

      Unlike broad oncology meetings, this conference focuses entirely on hematologic malignancies. The concentrated format allows for deeper discussion of treatment sequencing, emerging therapies, toxicity management, and evolving standards of care.

    • Who should attend the Lymphoma, Leukemia & Myeloma Congress?

      The meeting is designed for hematologists, medical oncologists, advanced practice providers, fellows, and oncology professionals involved in the care of patients with lymphoma, leukemia, and multiple myeloma. It is ideal for clinicians seeking practical, up-to-date guidance they can apply immediately in practice.

Back to top